Transradial Access Market Professional Survey Report 2018: Terumo Medical Corporation, AngioDynamics, Stryker, Teleflex Incorporated, Smiths Group, Medtronic, Boston Scientific, Edwards Lifesciences, Nipro Medical Corporation, Merit Medical Systems, Oscor

This report focuses on the global Transradial Access status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transradial Access development in United States, Europe and China.

The global transradial access market analysis is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of transradial access market for global, Europe, North America, Asia Pacific and South America.

Download sample copy of this report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-transradial-access-market

Report synopsis

1. To analyse the market size of the market and infer the key trends from it.

2. Industry Chain Suppliers of Transradial Access market with Contact Information

3. Historical, current and projected market size in terms of volume and value

4. In-depth market segmentation of Transradial Access

5. Comprehensive quantitative analysis of the industry is provided for the period of 2018-2025 to assist stakeholders to capitalize on the prevailing market opportunities.

Major Market Drivers and Restraints:

• Awareness towards the obesity and heart related problems.

• Increase in the use of chemotherapy.

• Development of interventional procedures using radial artery access

• Increased investment in research and development of technology

• Downward pricing pressure owing to its commodity nature

• Increase in prevalence of obese patients

Major Topics Covered:

1. Introduction
2. Market Segmentation
3. Executive Summary
4. Market Overview
5. Premium Insights
6. Global Transradial Access Market: Regulatory Scenario
7. Global Transradial Access Market, By Application
8. Global Transradial Access Market, By Product
9. Global Transradial Access Market, By End User
10. Global Transradial Access Market, By Geography
11. Global Transradial Access Market, Company Landscape
12. Company Profiles
13. Related Reports

Download Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=global-transradial-access-market

Big Players

Cardinal Health
Stryker
Angiodynamics Inc.

Other players in this market include BD, Terumo Corporation, Teleflex Incorporated, Smiths Group plc, MEDTRONIC, Boston Scientific Corporation, Edwards Lifesciences Corporation, Merit Medical Systems Inc., NIPRO CORPORATION, Amecath, OSCOR Inc. and Penumbra among others holds 7.8% of the global transradial access system market in 2017.

Cardinal Health:

Cardinal Health was founded in 1979 and headquartered at Ohio, U.S. The company offers its integrated healthcare services and products to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide.

The company has its network in more than 60 countries worldwide including U.S., Australia, Japan, Canada, China, Puerto Rico and other Europe, Middle East, Africa countries. Some of company’s subsidiaries are Cordis Corporation (U.S.), RGH Enterprises, Inc. (U.S.), Source Medical Corp (Canada), CareFusion (U.S.), Medicine Shoppe International, Inc (U.S.), Viasys Healthcare (U.S.), Tecomet, Inc (U.S.) among others.

Stryker:

Established in 1941 and headquartered at Michigan, U.S. Stryker is a one of the leading medical technologies company. The company provides products through three business segment Neurotechnology and Spine, MedSurg and Orthopaedics. The Neurotechnology and Spine segment offering include products related to neurotechnology.

Recent Developments:

In October, 2010, Stryker Corporation entered into an agreement to acquire the assets of the Neurovascular division of Boston Scientific (U.S.) in an all cash transaction for USD 1.5 billion. This acquisition is a very important strategic move and will strengthen company’s space in neurovascular portfolio.

Angiodynamics Inc.-

Angiodynamics Inc. was founded in 1988 and headquartered at New York, U.S. The company is engaged in manufacturing and marketing of medical devices for vascular access, peripheral vascular disease, oncology and surgical settings. The company has three global operational business segments- vascular access, peripheral vascular products, oncology / surgery.

Transradial access products such as guidewires and catheters are offered by vascular access as well as peripheral vascular products. Its manufacturing facilities are FDA registered, certified with ISO 13485 standards and CMD/CAS Canadian Medical Device in European Union countries.

The company has its network in the United States, Europe and Asia. It sells products in more than 50 markets through direct sales and distributors. Few subsidiaries of Angiodynamics Inc are Navilyst Medical (U.S.), Microsulis Medical Limited (U.K.), Clinical Devices, B.V (Netherlands), Leocor, Inc (Germany), Vortex Medical, Inc (U.S.), RITA Medical Systems LLC (U.S), oncobionic (U.S.) among others.

Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transradial-access-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.